Molecular abnormalities in pediatric embryonal brain tumors - Analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22

Clinical Neuropathology

Volumn 23, Issue 5, 2004, Pages 209-217

  Zakrzewska, M ^a   Rieske, P ^a   Debiec Rychter, M ^b   Zakrzewski, ^c   Polis, L ^c   Fiks, T ^c   Liberski, P P ^a,c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Brain tumors; Embryonal tumors; Loss of heterozygosity; Medulloblastoma; PNET

Indexed keywords

ADOLESCENT; ARTICLE; AXIN1 GENE; BRAIN TUMOR; CHILD; CHROMOSOME 10Q; CHROMOSOME 11P; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME 5Q; CHROMOSOME 9Q; CHROMOSOME DELETION; CLINICAL ARTICLE; DMBT1 GENE; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HETEROZYGOSITY LOSS; HSNF5 GENE; HUMAN; HUMAN TISSUE; INI1 GENE; ISOCHROMOSOME; MALE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; PRIORITY JOURNAL; PTCH1 GENE; PTCH2 GENE; PTEN GENE; SUFU GENE; SUPPRESSOR GENE; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; LOSS OF HETEROZYGOSITY; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL;

EID: 4544329816     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Adesina AM, Nalbantoglu J, Cavenee WK 1994 p53 mutation and mdm2 gene amplification are uncommon in medulloblastoma. Cancer Res 54: 5649-5651
2. Albrecht S, von Daimling A, Pietsch T, Giangaspero F, Brandner S, Kleihues P, Wiestler OD 1994 Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas. Neuropathol Appl Neurobiol 20: 74-81
3. Aldosari N, Ahmed Rasheed BK, McLendon RE, Friedman HS, Bigner DD, Bigner SH 2000 Characterization of chromosome 17 abnormalities in medulloblastomas. Acta Neuropathol (Berl) 99: 345-351
4. Avet-Loiseau H, Venaut AM, Terrier-Lacombe MJ, Lellouch-Tubiana A, Zerah M, Vassal G 1999 Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumors in children. Br J Cancer 79: 1843-1847
5. Bayani J, Zielenska M, Marrano P, Kwan Ng Y, Taylor MD, Jay V, Rutka JT, Squire JA 2000 Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization and spectral karyotyping. J Neurosurg 93: 437-448
6. Bhattacharjee MB, Armstrong DD, Vogel H, Cooley LD 1997 Cytogenetic analysis of 120 primary pediatric brain tumors and literature review. Cancer Genet Cytogenet 97: 39-53
7. Biegel JA, Burk CD, Barr FG Emanuel BS 1992 Evidence for a 17p tumor-related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 52: 3391-3395
8. Biegel JA, Rorke LB, Janss AJ, Sutton LN, Parmiter AH 1995 Isochromosome 17q demonstrated by interphase fluorescence in situ hybridization in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer 14: 85-96
9. Biegel JA 1999 Cytogenetics and molecular genetics of childhood brain tumors. Neurooncology 2: 139-51
10. Biegel JA, Fogelgren B, Zhou JY, James CD, Janss AJ, Allen JC, Zagzag D, Raffel C, Rorke LB 2000 Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system. Clin Cancer Res 6: 2759-2763
11. Biegel JA, Kalpana G, Knudsen ES, Packer RJ, Roberts CW, Thiele CJ, Weissman B, Smith M 2002 The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res 62: 323-328
12. Bigner SH, McLendon RE, Fuchs H, McKeever PE, Friedman HS 1997 Chromosomal characteristics of childhood brain tumors. Cancer Genet Cytogenet 97: 125-134
13. Blaeker H, Ahmed Rasheed BK, McLendon RE, Friedman HS, Batra SK, Fuchs HE, Bigner SH 1999 Microsatellite analysis of childhood brain tumors. Genes Chromosomes Cancer 15: 54-63
14. Burnett ME, White EC, Sih S, von Haken MS, Cogen PH 1997 Chromosome arm 17 deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. Cancer Genet Cytogenet 97: 25-31
15. Burns AS, Jaros E, Cole M, Perry R, Pearson AJ, Lunec J 2002 The molecular pathology of p53 in primitive neuroectodermal tumors of the central nervous system. Br J Cancer 86: 117-1123
16. Cogen PH, McDonald JD 1996 Tumor suppressor genes and medulloblastoma. J Neurooncol 29: 103-112
17. Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sorensen N, Berthold F, Berens J, Birchmeier W, Wiestler OD, Pietsch T 2001 Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 61: 7039-7043
18. Eberhart CG, Kratz JE, Schuster A, Goldthwaite P, Cohen KJ, Perlman EJ, Burger PC 2002 Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol 12: 36-44
19. Fujii Y, Hongo T, Hayashi Y 1994 Chromosomal analysis of brain tumors in childhood. Genes Chromosomes Cancer 11: 205-215
20. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F 2002 Childhood cancer survival in Europe and the United States. Cancer 95: 1767-1772
21. Gilbertson R, Wickramasinghe C, Hernan R, Balaji V, Hunt D, Jones-Wallace D, Crolla J, Perry R, Lunec J, Pearson A, Ellison D 2001 Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer 85: 705-712
22. Huang H, Mahler-Arujo BM, Sankila A, Chimelli L, Yonekawa Y, Kleihues P, Ohgaki H 2000 APC mutations in sporadic medulloblastomas. Am J Pathol 156: 433-437
23. Izraeli S, Lowe LA, Bertness VL, Campaner S, Hahn H, Kirsch IR, Kuehn MR 2001 Genetic evidence that Sil is required for the Sonic hedgehog response pathway. Genesis 31: 72-77
24. Kleihues P, Cavenee WK 2000 Pathology and genetics of tumors of the nervous system. IARC Press, Lyon
25. Koch A, Waha A, Tonn JC, Sorensen N, Berthold F, Wolter M, Reifenberger J, Hartmann W, Friedl W, Reifenberger G, Wiestler OD, Pietsch T 2000 Somatic mutations of Wnt/Wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 93: 445-449
26. Kraus JA, Koch A, Albrecht S, Von Deimling A, Wiestler OD, Pietsch T 1996 Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma. Int J Cancer 67: 11-15
27. Kraus JA, Oster C, Sorensen N, Berthold F, Schlegel U, Tonn JC, Wiestler OD, Pietsch T 2002 Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumor suppressor gene. Neuropathol Appl Neurobiol 28: 136-141
28. Krynska B, Del Valle L, Gordon Gorrion J, Otte J, Croul S, Khalili K 2000 Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma. Virology 274: 65-74
29. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A, Poustka A 1997 DMBT1, a new member of the SRCR super-family, on chromosome 10q25.3-q26.1 is deleted in malignant brain tumors. Nat Genet 17: 32-39
30. Nam DH, Wang KC, Kim YM, Chi JG, Kim SK, Cho BK 2000 The effect of isochromosome 17q presence, proliferative and apoptotic indices, expression of c-erb2, bcl-2and p53 proteins on the prognosis of medulloblastoma. J Korean Med Sci 15: 452-456
31. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR 2002 Prediction of central nervous system embryonal tumor outcome based on gene expression. Nature 415: 436-442
32. Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW, James CD 1997 Sporadic medulloblastomas contain PTCH mutations. Cancer Res 57: 842-845
33. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH 1997 PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57: 4187-4190
34. Reardon DA, Michalkiewicz E, Boyett JM, Sublett JE, Entrekin RE, Ragsdale ST, Valentine MB, Behm FG, Li H, Heideman RL, Kun LE, Shapiro DN, Look AT 1997 Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 57: 4042-4047
35. Roberts RO, Lynch CF, Jones MP, Hart MN MY 1991 Medulloblastoma: a population-based study of 532 cases. J Neuropathol Exp Neurol 50: 134-144
36. Rubin JB, Rowitch DH 2002 Medulloblastoma: a problem of developmental biology. Cancer Cell 2: 7-8
37. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G, Collins VP, Feuerstein BG 1999 Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 86. 331-339
38. Scheurlen WG Schwabe GC, Joos S, Mollenhauer J, Sorensen N, Kuhl J 1998 Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor clinical outcome. J Clin Oncol 16: 2478-2485
39. Scheurlen WG, Schwabe GC, Seranski P, Joos S, Harbott J, Metzke S, Dohner H, Poustka A, Wilgenbus K, Haas OA 1999 Mapping of the break points on the short arm of chromosome 17 in neoplasms with an i(17q). Genes Chromosomes Cancer 25: 230-240
40. Schofield D, West DC, Anthony DC, Marshal R, Sklar J 1995 Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas. Am J Pathol 146: 472-480
41. Sevenet N, Lellouch-Tubiana A, Schoefield D, Hoang-Xuan K, Gessler M, Birnbaum D, Jeanpierre C, Jouvet A, Dellatre O 1999 Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 13:2359-2368
42. Shlomit R, Ayala AG, Michal D, Ninett A, Frida S, Boleslaw G, Gad B, Gideon R, Shlomi C 2000 Gains and losses of DNA sequences in childhood brain tumors analyzed by comparative genomic hybridization. Cancer Genet Cytogenet 121: 67-72
43. Smyth I, Narang MA, Evans T, Heimann C, Nakamura Y, Chenevix-Trench G, Pietsch T, Wicking C, Wainwright BJ 1999 Isolation and characterization of human patched 2 (PTCH2), a putative tumor suppressor gene in basal cell carcinoma and medulloblastoma on chromosome 1p32. Hum Mol Genet 8: 291-297
44. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, Hao A, Goldstein AM, Stavrou T, Scherer SW, Dura WT, Wainwright B, Squire JA, Rutka JT, Hogg D 2002 Mutations in SUFU predispose to medulloblastoma. Nat Genet 31: 306-310
45. Thomas GA, Raffel C 1991 Loss of heterozygosity on 6q, 16q and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res 51: 639-643
46. Ward S, Harding B, Wilkins P, Harkness W, Hayward R, Darling JL, Thomas DG, Warr T 2001 Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Genes Chromosomes Cancer 32: 59-66
47. Wilgenbus KK, Seranski P, Brown A, Leuchs B, Mincheva A, Lichter P, Poustka A 1997 Molecular characterization of a genetically unstable region containing the SMS critical area a breakpoint cluster for human PNETs. Genomics 42: 1-10
48. Yin XL, Pang JC, Pang JC, Liu YH, Chong EY, Cheng Y, Poon WS, Ng HK 2001 Analysis of loss of heterozygosity on chromosomes 10q, 11, and 16 in medulloblastomas. J Neurosurg 94: 799-805
49. Yokota N, Nishizawa S, Ohta S, Date H, Sugimura H, Namba H, Maekawa M 2002 Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 101: 198-201